Terveystalo's maiden results reveal 26% revenue growth and an almost 27% increase in adjusted EBITDA for 2017 - but most of that comes from acquisitions which, along with IPO costs, has halved the company's earnings-per-share and profit for the period. Healthcare Europa looks at the results with an analyst to find out more. Subscribers login here to carry on reading.
Not a subscriber? Want to read the full stories? Why not subscribe today?
If you would like to find out more click here to request a guided tour of the website with one of the team.
We would welcome your thoughts on this story. Email your views to Cameron Murray or call 0207 183 3779.
The only information source for private healthcare services in Europe, click here to download a brochure